Stories
India's Drug Regulator Warns Against Indiscriminate Painkiller and Antibiotic Use
- •The Central Drugs Standard Control Organisation (CDSCO) has issued a warning regarding the inappropriate use of painkillers (NSAIDs) and antibiotics due to associated health risks.
- •The circular advises healthcare professionals, pharmacies, and hospitals to ensure appropriate use and adherence to prescription requirements for these medicines.
- •NSAIDs can interfere with kidney blood flow, especially in individuals with pre-existing kidney conditions, potentially leading to acute kidney injury and worsening existing kidney disease.
- •The CDSCO explicitly warns against self-medication with antibiotics, emphasizing their use only when clinically indicated for bacterial infections, not viral ones.
- •The primary concern with indiscriminate antibiotic use is antimicrobial resistance, adverse drug reactions, and unnecessary exposure, rather than routine use being a major cause of Chronic Kidney Disease (CKD).
Key Questions Answered
The Central Drugs Standard Control Organisation (CDSCO) warned against the indiscriminate use and self-medication of non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics, highlighting their associated risks to kidney health and antimicrobial resistance.
NSAIDs inhibit the production of prostaglandins, which are substances that help maintain adequate blood flow to the kidneys. Prolonged or high-dose use can interfere with kidney circulation, potentially causing acute kidney injury, water retention, and chronic kidney disease progression in susceptible people.
Many NSAID painkillers are covered under Schedule H, while most antibiotics fall under Schedule H1 of the Drugs Rules, 1945. This legal classification means their sale strictly requires a valid medical prescription rather than over-the-counter self-medication.
